Chris Fenimore

Chris Fenimore joined Regeneron in 2003 and, as the current Head of Accounting and Controller, has global responsibility for SEC reporting, accounting and accounting operations, and internal control over financial reporting, administration of financial systems, accounts payable and payroll. Prior to his current role, he served as Regeneron’s Vice President of Financial Planning, and prior to joining Regeneron, he was Vice President of Finance at Mojave Therapeutics, Inc. He has prior experience in healthcare industry-focused venture capital and investment banking roles, as well as serving as an audit senior at KPMG. Mr. Fenimore holds an MA in Biotechnology from Columbia University, an MBA in Professional Accounting from Rutgers Business School and a BA in Economics from Rutgers University. Mr. Fenimore is a Certified Public Accountant in the State of New York.